HPV DNA positivity by type and gender
| Women | Men | |
| % (95% CI) | % (95% CI) | |
| Denominator* | 1525, 1851 | 1545, 1272 |
| HPV type | ||
| Any HPV | 29.0 (26.7 to 31.3) | 17.4 (15.1 to 19.8) |
| Any high risk† | 15.9 (14.1 to 17.8) | 9.6 (8.0 to 11.6) |
| 2+ high-risk types† | 3.4 (2.6 to 6.6) | 2.6 (1.3 to 4.9) |
| High-risk type(s) 16 and/or 18 | 5.5 (4.5 to 6.8) | 3.0 (2.1 to 4.3) |
| High-risk type(s) 16 and/or 18 only | 4.1 (3.1 to 5.2) | 2.6 (1.8 to 3.9) |
| Low-risk type(s) 6 and/or 11 | 4.7 (3.8 to 5.9) | 2.2 (1.5 to 3.1) |
| Types 6/11/16/18 | 9.8 (8.4 to 11.3) | 4.8 (3.7 to 6.3) |
| LR HPV-6 | 3.1 (2.3 to 4.2) | 1.1 (0.7 to 1.9) |
| LR HPV-11 | 2.4 (1.8 to 3.3) | 1.2 (0.7 to 2.0) |
| HR HPV-16 | 4.2 (3.3 to 5.3) | 2.3 (1.5 to 3.5) |
| HR HPV-18 | 1.4 (0.9 to 2.2) | 0.7 (0.3 to 1.4) |
| LR HPV-26 | 0.9 (0.5 to 1.6) | 0.3 (0.1 to 1.0) |
| HR HPV-31 | 0.6 (0.3 to 1.1) | 0.3 (0.1 to 0.9) |
| HR HPV-33 | 0.9 (0.6 to 1.5) | 0.4 (0.1 to 0.9) |
| HR HPV-35 | 1.0 (0.6 to 1.6) | 1.0 (0.5 to 1.8) |
| HR HPV-39 | 1.0 (0.6 to 1.6) | 0.7 (0.3 to 1.5) |
| HR HPV-45 | 0.7 (0.4 to 1.2) | 0.8 (0.4 to 1.6) |
| HR HPV-51 | 1.9 (1.3 to 2.7) | 1.5 (1.0 to 2.4) |
| HR HPV-52 | 2.3 (1.7 to 3.2) | 1.1 (0.6 to 1.9) |
| LR HPV-53 | 2.0 (1.4 to 2.8) | 0.8 (0.4 to 1.5) |
| HR HPV-56 | 1.4 (0.9 to 2.1) | 0.9 (0.5 to 1.9) |
| HR HPV-58 | 1.7 (1.2 to 2.4) | 0.6 (0.3 to 1.2) |
| HR HPV-59 | 1.0 (0.5 to 1.8) | 0.2 (<0.01 to 0.6) |
| LR HPV-66 | 0.9 (0.5 to 1.5) | 0.6 (0.3 to 1.2) |
| HR HPV-68 | 1.8 (1.2 to 2.7) | 0.9 (0.5 to 1.7) |
| LR HPV-70 | 1.0 (0.6 to 1.6) | 0.4 (0.1 to 0.9) |
| LR HPV-73 | 0.9 (0.6 to 1.5) | 0.4 (0.2 to 1.0) |
| LR HPV-82 | <0.01 (<0.01 to 0.3) | <0.01 (<0.01 to 0.6) |